Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
1776
DELISTED
Emcore Corp
EMKR
| $4.03M | ﹤0.01% |
126,844
+10,617
| +9% | +$300K |
|
1777
Preformed Line Products
PLPC
$2.27B
| $4.03M | ﹤0.01% |
80,600
+100
| +0.1% | +$4.87K |
|
1778
Dine Brands
DIN
$447M
| $4.03M | ﹤0.01% |
95,600
-656,300
| -87% | -$26.5M |
|
1779
First Business Financial Services
FBIZ
$598M
| $4.02M | ﹤0.01% |
244,365
-32,315
| -12% | -$505K |
|
1780
Comfort Systems
FIX
$62.4B
| $4.02M | ﹤0.01% |
98,600
+77,000
| +356% | +$2.74M |
|
1781
Alico
ALCO
$297M
| $4.01M | ﹤0.01% |
128,696
+10,191
| +9% | +$303K |
|
1782
Hanover Insurance
THG
$7.84B
| $4M | ﹤0.01% |
39,500
-26,300
| -40% | -$2.58M |
|
|
GLOG
1783
DELISTED
GASLOG LTD
GLOG
| $4M | ﹤0.01% |
1,424,599
+206,800
| +17% | +$754K |
|
1784
Champion Homes
SKY
$5.13B
| $4M | ﹤0.01% |
164,220
-68,500
| -29% | -$1.43M |
|
1785
El Pollo Loco
LOCO
$473M
| $3.98M | ﹤0.01% |
269,600
+73,500
| +37% | +$943K |
|
|
XRN
1786
Chiron Real Estate Inc
XRN
$491M
| $3.98M | ﹤0.01% |
70,190
-39,120
| -36% | -$2.12M |
|
1787
Civista Bancshares
CIVB
$593M
| $3.97M | ﹤0.01% |
257,902
-67,389
| -21% | -$980K |
|
1788
Darling Ingredients
DAR
$10.6B
| $3.97M | ﹤0.01% |
161,300
-325,400
| -67% | -$7.09M |
|
|
SCHR
1789
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $3.96M | ﹤0.01% |
134,800
+10,540
| +8% | +$309K |
|
1790
Resources Connection
RGP
$145M
| $3.95M | ﹤0.01% |
330,142
+56,642
| +21% | +$614K |
|
1791
EnerSys
ENS
$7.42B
| $3.95M | ﹤0.01% |
+61,300
| New | +$3.61M |
|
1792
Northrim BanCorp
NRIM
$606M
| $3.94M | ﹤0.01% |
627,600
-29,600
| -5% | -$172K |
|
|
AIU
1793
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $3.93M | ﹤0.01% |
8,009
+1,903
| +31% | +$1.01M |
|
1794
United-Guardian
UG
$32.8M
| $3.92M | ﹤0.01% |
264,600
-2,670
| -1% | -$39.9K |
|
1795
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
| $3.91M | ﹤0.01% |
+147,300
| New | +$3.84M |
|
|
ODP
1796
DELISTED
ODP
ODP
| $3.9M | ﹤0.01% |
+165,902
| New | +$3.62M |
|
1797
Eastern Company
EML
$153M
| $3.89M | ﹤0.01% |
217,899
-501
| -0.2% | -$9.16K |
|
1798
Blue Owl Capital
OBDC
$5.78B
| $3.89M | ﹤0.01% |
315,800
+217,200
| +220% | +$2.68M |
|
1799
Sabre
SABR
$900M
| $3.89M | ﹤0.01% |
482,700
-2,775,400
| -85% | -$19.7M |
|
|
VIOT
1800
Viomi Technology
VIOT
$47.2M
| $3.88M | ﹤0.01% |
731,532
+288,700
| +65% | +$1.58M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.